These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 16302251)

  • 1. Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy.
    Djemli A; Khetani K; Auger M
    Cancer; 2006 Feb; 108(1):21-6. PubMed ID: 16302251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid pre-screening of cervical smears as a method of internal quality control in a cervical screening programme.
    Tavares SB; de Sousa NL; Manrique EJ; de Albuquerque ZB; Zeferino LC; Amaral RG
    Cytopathology; 2008 Aug; 19(4):254-9. PubMed ID: 18476988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metaanalysis of the accuracy of rapid prescreening relative to full screening of pap smears.
    Arbyn M; Schenck U; Ellison E; Hanselaar A
    Cancer; 2003 Feb; 99(1):9-16. PubMed ID: 12589640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of cytotechnologists' parameters with their performance in rapid prescreening of papanicolaou smears.
    Djemli A; Khetani K; Case BW; Auger M
    Cancer; 2006 Oct; 108(5):306-10. PubMed ID: 16948125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process.
    Renshaw AA; DiNisco SA; Minter LJ; Cibas ES
    Cancer; 1997 Oct; 81(5):272-6. PubMed ID: 9349513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening?
    Kanber Y; Charbonneau M; Auger M
    Cancer Cytopathol; 2015 Dec; 123(12):739-44. PubMed ID: 26348845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One hundred percent thorough quality control rescreening of liquid-based monolayers in cervicovaginal cytopathology.
    Rowe LR; Marshall CJ; Bentz JS
    Cancer; 2002 Dec; 96(6):325-9. PubMed ID: 12478679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid prescreening as a quality assurance measure in cervical cytology.
    Repse-Fokter A; Caks-Golec T
    Acta Cytol; 2009; 53(3):268-70. PubMed ID: 19534265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the performance of rapid prescreening, 10% random review, and clinical risk criteria as methods of internal quality control in cervical cytopathology.
    Tavares SB; Alves de Sousa NL; Manrique EJ; Pinheiro de Albuquerque ZB; Zeferino LC; Amaral RG
    Cancer; 2008 Jun; 114(3):165-70. PubMed ID: 18454462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of rapid prescreening and 10% rescreening in liquid-based Papanicolaou testing.
    Currens HS; Nejkauf K; Wagner L; Raab SS
    Am J Clin Pathol; 2012 Jan; 137(1):150-5. PubMed ID: 22180489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid prescreen of cervical liquid-based cytology preparations: results of a study in an academic medical center.
    Frable WJ; Pedigo MA; Powers CN; Yarrell C; Ortiz B; Clark ME; Ebron T
    Diagn Cytopathol; 2012 Aug; 40(8):691-7. PubMed ID: 22807384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in the routine screening of cervical smears: A study using rapid prescreening and 100% rapid review as internal quality control methods.
    Tavares SB; Alves de Sousa NL; Manrique EJ; Pinheiro de Albuquerque ZB; Zeferino LC; Amaral RG
    Cancer Cytopathol; 2011 Dec; 119(6):367-76. PubMed ID: 21954191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of 100% rapid rescreening of negative cervical smears as a quality assurance measure.
    Manrique EJ; Amaral RG; Souza NL; Tavares SB; Albuquerque ZB; Zeferino LC
    Cytopathology; 2006 Jun; 17(3):116-20. PubMed ID: 16719853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ThinPrep Papanicolaou testing to reduce false-negative cervical cytology.
    Linder J; Zahniser D
    Arch Pathol Lab Med; 1998 Feb; 122(2):139-44. PubMed ID: 9499356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid prescreening is as effective at reducing screening error as postscreening with the FocalPoint automated screening device.
    Wilgenbusch H; Mueller G; Neal M; Renshaw AA
    Diagn Cytopathol; 2011 Nov; 39(11):818-21. PubMed ID: 20949451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of p16INK4a as a diagnostic tool in the triage of Pap smears demonstrating atypical squamous cells of undetermined significance.
    Duncan L; Jacob S; Hubbard E
    Cancer; 2008 Feb; 114(1):34-48. PubMed ID: 18186493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of AutoPap system-assisted and manual cytologic screening. A comparison.
    Wertlake P
    J Reprod Med; 1999 Jan; 44(1):11-7. PubMed ID: 9987733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy.
    Renshaw A
    Cancer; 2006 Aug; 108(4):267; author reply 268. PubMed ID: 16671112
    [No Abstract]   [Full Text] [Related]  

  • 19. The PAPNET system for quality control of cervical smears: validation and limits.
    Cenci M; Nagar C; Giovagnoli MR; Vecchione A
    Anticancer Res; 1997; 17(6D):4731-4. PubMed ID: 9494597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated screening for quality control using PAPNET: a study of 638 negative Pap smears.
    Keyhani-Rofagha S; Palma T; O'Toole RV
    Diagn Cytopathol; 1996 Jun; 14(4):316-20. PubMed ID: 8725131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.